Health Canada approves new Moderna mRNA-flu vaccine
Health Canada has authorized a combined mRNA COVID-19 and influenza vaccine from Moderna for use in Canada.
Health Canada announced the approval of a new combined mRNA vaccine that targets both COVID-19 and seasonal influenza, developed by Moderna. The agency said the product meets safety and efficacy standards required for distribution across the country. The approval is expected to expand vaccination options and simplify immunisation schedules for Canadians.
"The addition of a combined mRNA COVID-19 and flu vaccine will help protect Canadians against two major respiratory illnesses with a single shot," a Health Canada spokesperson said.